Sort
39,280 grants matching “leukemia”
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
$1,009,106Martin Carroll · University Of Pennsylvania · U54 · FY2024 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,008,900David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Towards targeting the lymphoma microenvironment
$1,008,898Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,008,827Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Genetic Discovery and Application in a Clinical Setting Continuing a Partnership
$1,008,813Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2014 · HG
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,008,673Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Bio-Therapies for the Treatment of Cancer
$1,008,466David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,007,191Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Spectral imaging for automated malignant blast counting
$1,006,481Richard M. Levenson · Cambridge Research And Instrumentation · R44 · FY2007 · CA
Mechanisms of nonsense-mediated mRNA decay target selection
$1,006,078John Hogg · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
SEARCH FOR SELECTIVE THERAPY OF CML
$1,006,014Sloan-Kettering Institute For Cancer Res · P01 · FY2000 · CA
Humanized Mouse Avatars for T1D
$1,005,973Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · U01 · FY2022 · DK
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting
$1,005,807Ulrich Steidl · Albert Einstein College Of Medicine · R35 · FY2025 · CA
Chemoprevention of Basal Cell Carcinomas with Tazarotene
$1,005,301Ervin H Epstein · Children'S Hospital & Res Ctr At Oakland · R01 · FY2008 · CA
Metabolic gatekeepers in B-cell malignancies
$1,005,000Markus Mãschen · Yale University · R35 · FY2021 · CA
Novel DNA Repair Inhibitors for Cancer Therapy
$1,005,000Peter M Glazer · Yale University · R35 · FY2018 · CA
Metabolic gatekeepers in B-cell malignancies
$1,004,945Markus Mãschen · Yale University · R35 · FY2025 · CA
Novel DNA Repair Inhibitors for Cancer Therapy
$1,004,921Peter M Glazer · Yale University · R35 · FY2020 · CA
Novel DNA Repair Inhibitors for Cancer Therapy
$1,004,920Peter M Glazer · Yale University · R35 · FY2021 · CA
Molecular pathways and targeted therapies in human leukemia
$1,004,909Adolfo A. Ferrando · Columbia University Health Sciences · R35 · FY2020 · CA
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,004,845Brian J Druker · Oregon Health & Science University · U01 · FY2017 · CA
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,004,844Brian J Druker · Oregon Health & Science University · U01 · FY2020 · CA
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,004,844Brian J Druker · Oregon Health & Science University · U01 · FY2018 · CA
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,004,844Brian J Druker · Oregon Health & Science University · U01 · FY2021 · CA
Retrovirus Assembly and Maturation
$1,004,545Alan Rein · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA